These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 10188074)

  • 1. Bone marrow transplantation in multiple myeloma.
    Schlossman RL; Anderson KC
    Curr Opin Oncol; 1999 Mar; 11(2):102-8. PubMed ID: 10188074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel biologically based therapies for myeloma.
    Anderson KC
    Cancer J; 2001; 7 Suppl 1():S19-23. PubMed ID: 11504280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of high-dose chemotherapy in the treatment of multiple myeloma: a controversy.
    Kyle RA
    Ann Oncol; 2000; 11 Suppl 1():55-8. PubMed ID: 10707780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose therapy in multiple myeloma.
    Samson D
    Curr Opin Hematol; 1996 Nov; 3(6):446-52. PubMed ID: 9372116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of myeloma.
    Smith ML; Newland AC
    QJM; 1999 Jan; 92(1):11-4. PubMed ID: 10209667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensive treatment strategies in multiple myeloma.
    Kovacsovics TJ; Delaly A
    Semin Hematol; 1997 Jan; 34(1 Suppl 1):49-60. PubMed ID: 9122746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced-intensity allogeneic hematopoietic stem cell transplantation for multiple myeloma: a concise review.
    Salit RB; Bishop MR
    Clin Lymphoma Myeloma Leuk; 2011 Jun; 11(3):247-52. PubMed ID: 21658650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salvage autologous or allogeneic transplantation for multiple myeloma refractory to or relapsing after a first-line autograft?
    Mehta J; Tricot G; Jagannath S; Ayers D; Singhal S; Siegel D; Desikan K; Munshi N; Fassas A; Mattox S; Vesole D; Crowley J; Barlogie B
    Bone Marrow Transplant; 1998 May; 21(9):887-92. PubMed ID: 9613780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of multiple myeloma.
    San Miguel JF; Bladé Creixenti J; García-Sanz R
    Haematologica; 1999 Jan; 84(1):36-58. PubMed ID: 10091392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and clinical remissions in multiple myeloma: role of autologous and allogeneic transplantation of hematopoietic cells.
    Corradini P; Voena C; Tarella C; Astolfi M; Ladetto M; Palumbo A; Van Lint MT; Bacigalupo A; Santoro A; Musso M; Majolino I; Boccadoro M; Pileri A
    J Clin Oncol; 1999 Jan; 17(1):208-15. PubMed ID: 10458235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High intensity regimens with autologous hematopoietic stem cell transplantation as treatment of multiple myeloma.
    Awedan AA
    Ann Transplant; 2002; 7(2):38-43. PubMed ID: 12416471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of haematopoietic stem cell-supported myeloablative therapy for the management of multiple myeloma.
    Cavo M; Benni M; Gozzetti A; Tura S
    Baillieres Clin Haematol; 1995 Dec; 8(4):795-813. PubMed ID: 8845573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic stem cell autografts in support of myeloablative therapy for multiple myeloma.
    Barlogie B; Jagannath S; Vesole D; Tricot G
    J Hematother; 1994; 3(2):149-53. PubMed ID: 7922016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The current status of hematopoietic stem cell transplantation for multiple myeloma.
    Bensinger WI
    Clin Adv Hematol Oncol; 2004 Jan; 2(1):46-52. PubMed ID: 16163159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in the autologous and allogeneic transplantation strategies for multiple myeloma.
    Nishihori T; Alsina M
    Cancer Control; 2011 Oct; 18(4):258-67. PubMed ID: 21976244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syngeneic transplantation in multiple myeloma - a case-matched comparison with autologous and allogeneic transplantation. European Group for Blood and Marrow Transplantation.
    Gahrton G; Svensson H; Björkstrand B; Apperley J; Carlson K; Cavo M; Ferrant A; Fouillard L; Gratecos N; Gratwohl A; Guilhot F; Lambertenghi Deliliers G; Ljungman P; Masszi T; Milligan DW; Powles RL; Reiffers J; Samson JD; Stoppa AM; Vernant JP; Volin L; Wallvik J
    Bone Marrow Transplant; 1999 Oct; 24(7):741-5. PubMed ID: 10516677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of allografting with autografting for newly diagnosed myeloma.
    Bruno B; Rotta M; Patriarca F; Mordini N; Allione B; Carnevale-Schianca F; Giaccone L; Sorasio R; Omedè P; Baldi I; Bringhen S; Massaia M; Aglietta M; Levis A; Gallamini A; Fanin R; Palumbo A; Storb R; Ciccone G; Boccadoro M
    N Engl J Med; 2007 Mar; 356(11):1110-20. PubMed ID: 17360989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibody-purged bone marrow transplantation therapy for multiple myeloma.
    Anderson KC; Andersen J; Soiffer R; Freedman AS; Rabinowe SN; Robertson MJ; Spector N; Blake K; Murray C; Freeman A
    Blood; 1993 Oct; 82(8):2568-76. PubMed ID: 8400304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic bone marrow transplantation in multiple myeloma.
    Gahrton G
    Pathol Biol (Paris); 1999 Feb; 47(2):188-91. PubMed ID: 10192887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second autologous or allogeneic transplantation after the failure of first autograft in patients with multiple myeloma.
    Qazilbash MH; Saliba R; De Lima M; Hosing C; Couriel D; Aleman A; Roden L; Champlin R; Giralt SA
    Cancer; 2006 Mar; 106(5):1084-9. PubMed ID: 16456814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.